Artificial intelligence is creating new opportunities to transform healthcare, from improving clinical decision-making to identifying disease earlier and delivering safer, more effective care. Realizing this potential requires more than technological advancement; it demands a vision for how innovation can translate into meaningful impact for patients and health systems.

One of those visionaries is Christopher Longhurst, MD, founding Executive Director of the Joan & Irwin Jacobs Center for Health Innovation (JCHI). Dr. Longhurst was recently elected to the National Academy of Medicine (NAM), which recognizes his contributions to this evolving field and underscores the importance of the work JCHI continues to advance.

Founded in 2021, JCHI is at the forefront of healthcare innovation, bringing together clinicians, researchers, technology experts and industry leaders to translate emerging technologies into real-world solutions. From AI-powered clinical decision support to digital health tools, wearables and connected data platforms, JCHI is advancing a vision of healthcare that is more proactive, data-informed and centered on better outcomes for patients and communities.

Now CEO of Seattle Children’s, Dr. Longhurst is a nationally recognized leader in health AI and digital health innovation. His work has helped shape how health systems integrate information technology into clinical practice, demonstrating the potential of AI to improve care quality, strengthen clinical workflows and support better decision-making.

“Chris has helped shape how health systems across the country use information technology and AI to make care safer and better. His election to the National Academy of Medicine is a fitting honor, and as JCHI’s founding Executive Director, he holds a special place in our center’s history,” said Karandeep Singh, MD, JCHI Executive Director and Chief Health AI Officer at UC San Diego Health.

Reflecting on JCHI’s early years, Dr. Longhurst highlighted three milestones.

“When we founded JCHI, we focused on using technology to improve real health outcomes,” he said. ​“Three early experiences stand out: leveraging AI to improve the quality of sepsis care, developing the Mission Control Center, and recruiting Dr. Karandeep Singh. Each accomplishment reflects the creativity, dedication and collaboration of the broader JCHI team and has helped establish a strong foundation for the organization’s next chapter. As JCHI continues to grow under the leadership of Dr. Singh and Dr. Alex Khalessi, I am confident they will help lead the way in applying next-generation AI tools to optimize care across the patient journey.”

“As JCHI continues to grow under the leadership of Dr. Singh and Dr. Alex Khalessi, I am confident they will help lead the way in applying next-generation AI tools to optimize care across the patient journey.”

Looking ahead, Dr. Longhurst is especially excited to see how JCHI uses these tools to enable earlier disease identification through opportunistic screening and surveillance, with the potential to improve outcomes for patients and communities.

Dr. Longhurst’s election to NAM recognizes his lasting contributions to this evolving field and reinforces the importance of the mission he helped establish at JCHI: harnessing technology and AI to transform healthcare and improve lives.